img

Global Clinical Trials Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Clinical Trials Market Research Report 2024

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
According to MRAResearch’s new survey, global Clinical Trials market is projected to reach US$ 62370 million in 2033, increasing from US$ 46670 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trials market research.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research
Segment by Type
Phase I
Phase II
Phase III
Phase IV

Segment by Application


Interventional
Observational
Expanded Access
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Interventional
1.3.3 Observational
1.3.4 Expanded Access
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trials Market Perspective (2018-2033)
2.2 Clinical Trials Growth Trends by Region
2.2.1 Global Clinical Trials Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trials Forecasted Market Size by Region (2024-2033)
2.3 Clinical Trials Market Dynamics
2.3.1 Clinical Trials Industry Trends
2.3.2 Clinical Trials Market Drivers
2.3.3 Clinical Trials Market Challenges
2.3.4 Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trials Players by Revenue
3.1.1 Global Top Clinical Trials Players by Revenue (2018-2023)
3.1.2 Global Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trials Revenue
3.4 Global Clinical Trials Market Concentration Ratio
3.4.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2022
3.5 Clinical Trials Key Players Head office and Area Served
3.6 Key Players Clinical Trials Product Solution and Service
3.7 Date of Enter into Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trials Breakdown Data by Type
4.1 Global Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trials Forecasted Market Size by Type (2024-2033)
5 Clinical Trials Breakdown Data by Application
5.1 Global Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trials Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Clinical Trials Market Size (2018-2033)
6.2 North America Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Clinical Trials Market Size by Country (2018-2023)
6.4 North America Clinical Trials Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trials Market Size (2018-2033)
7.2 Europe Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Clinical Trials Market Size by Country (2018-2023)
7.4 Europe Clinical Trials Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials Market Size (2018-2033)
8.2 Asia-Pacific Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Clinical Trials Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trials Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trials Market Size (2018-2033)
9.2 Latin America Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Clinical Trials Market Size by Country (2018-2023)
9.4 Latin America Clinical Trials Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials Market Size (2018-2033)
10.2 Middle East & Africa Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Clinical Trials Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trials Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quintiles IMS
11.1.1 Quintiles IMS Company Detail
11.1.2 Quintiles IMS Business Overview
11.1.3 Quintiles IMS Clinical Trials Introduction
11.1.4 Quintiles IMS Revenue in Clinical Trials Business (2018-2023)
11.1.5 Quintiles IMS Recent Development
11.2 Paraxel International Corporation
11.2.1 Paraxel International Corporation Company Detail
11.2.2 Paraxel International Corporation Business Overview
11.2.3 Paraxel International Corporation Clinical Trials Introduction
11.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2018-2023)
11.2.5 Paraxel International Corporation Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Clinical Trials Introduction
11.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2018-2023)
11.3.5 Charles River Laboratories Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Detail
11.4.2 ICON plc Business Overview
11.4.3 ICON plc Clinical Trials Introduction
11.4.4 ICON plc Revenue in Clinical Trials Business (2018-2023)
11.4.5 ICON plc Recent Development
11.5 SGS SA
11.5.1 SGS SA Company Detail
11.5.2 SGS SA Business Overview
11.5.3 SGS SA Clinical Trials Introduction
11.5.4 SGS SA Revenue in Clinical Trials Business (2018-2023)
11.5.5 SGS SA Recent Development
11.6 Pharmaceutical Product Development, LLC
11.6.1 Pharmaceutical Product Development, LLC Company Detail
11.6.2 Pharmaceutical Product Development, LLC Business Overview
11.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2018-2023)
11.6.5 Pharmaceutical Product Development, LLC Recent Development
11.7 Wuxi AppTec Inc.
11.7.1 Wuxi AppTec Inc. Company Detail
11.7.2 Wuxi AppTec Inc. Business Overview
11.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2018-2023)
11.7.5 Wuxi AppTec Inc. Recent Development
11.8 PRA Health Sciences
11.8.1 PRA Health Sciences Company Detail
11.8.2 PRA Health Sciences Business Overview
11.8.3 PRA Health Sciences Clinical Trials Introduction
11.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2018-2023)
11.8.5 PRA Health Sciences Recent Development
11.9 Chiltern International Ltd.
11.9.1 Chiltern International Ltd. Company Detail
11.9.2 Chiltern International Ltd. Business Overview
11.9.3 Chiltern International Ltd. Clinical Trials Introduction
11.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2018-2023)
11.9.5 Chiltern International Ltd. Recent Development
11.10 INC Research
11.10.1 INC Research Company Detail
11.10.2 INC Research Business Overview
11.10.3 INC Research Clinical Trials Introduction
11.10.4 INC Research Revenue in Clinical Trials Business (2018-2023)
11.10.5 INC Research Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Clinical Trials Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global Clinical Trials Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Clinical Trials Market Share by Region (2018-2023)
Table 10. Global Clinical Trials Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Clinical Trials Market Share by Region (2024-2033)
Table 12. Clinical Trials Market Trends
Table 13. Clinical Trials Market Drivers
Table 14. Clinical Trials Market Challenges
Table 15. Clinical Trials Market Restraints
Table 16. Global Clinical Trials Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Clinical Trials Market Share by Players (2018-2023)
Table 18. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2022)
Table 19. Ranking of Global Top Clinical Trials Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Clinical Trials Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Clinical Trials Product Solution and Service
Table 23. Date of Enter into Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Clinical Trials Revenue Market Share by Type (2018-2023)
Table 27. Global Clinical Trials Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Clinical Trials Revenue Market Share by Type (2024-2033)
Table 29. Global Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Clinical Trials Revenue Market Share by Application (2018-2023)
Table 31. Global Clinical Trials Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Clinical Trials Revenue Market Share by Application (2024-2033)
Table 33. North America Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Clinical Trials Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Clinical Trials Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Clinical Trials Market Size by Country (2024-2033) & (US$ Million)
Table 48. Quintiles IMS Company Detail
Table 49. Quintiles IMS Business Overview
Table 50. Quintiles IMS Clinical Trials Product
Table 51. Quintiles IMS Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 52. Quintiles IMS Recent Development
Table 53. Paraxel International Corporation Company Detail
Table 54. Paraxel International Corporation Business Overview
Table 55. Paraxel International Corporation Clinical Trials Product
Table 56. Paraxel International Corporation Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 57. Paraxel International Corporation Recent Development
Table 58. Charles River Laboratories Company Detail
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories Clinical Trials Product
Table 61. Charles River Laboratories Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 62. Charles River Laboratories Recent Development
Table 63. ICON plc Company Detail
Table 64. ICON plc Business Overview
Table 65. ICON plc Clinical Trials Product
Table 66. ICON plc Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 67. ICON plc Recent Development
Table 68. SGS SA Company Detail
Table 69. SGS SA Business Overview
Table 70. SGS SA Clinical Trials Product
Table 71. SGS SA Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 72. SGS SA Recent Development
Table 73. Pharmaceutical Product Development, LLC Company Detail
Table 74. Pharmaceutical Product Development, LLC Business Overview
Table 75. Pharmaceutical Product Development, LLC Clinical Trials Product
Table 76. Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 77. Pharmaceutical Product Development, LLC Recent Development
Table 78. Wuxi AppTec Inc. Company Detail
Table 79. Wuxi AppTec Inc. Business Overview
Table 80. Wuxi AppTec Inc. Clinical Trials Product
Table 81. Wuxi AppTec Inc. Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 82. Wuxi AppTec Inc. Recent Development
Table 83. PRA Health Sciences Company Detail
Table 84. PRA Health Sciences Business Overview
Table 85. PRA Health Sciences Clinical Trials Product
Table 86. PRA Health Sciences Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 87. PRA Health Sciences Recent Development
Table 88. Chiltern International Ltd. Company Detail
Table 89. Chiltern International Ltd. Business Overview
Table 90. Chiltern International Ltd. Clinical Trials Product
Table 91. Chiltern International Ltd. Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 92. Chiltern International Ltd. Recent Development
Table 93. INC Research Company Detail
Table 94. INC Research Business Overview
Table 95. INC Research Clinical Trials Product
Table 96. INC Research Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 97. INC Research Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Trials Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Clinical Trials Market Share by Type: 2022 VS 2033
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Phase IV Features
Figure 7. Global Clinical Trials Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Clinical Trials Market Share by Application: 2022 VS 2033
Figure 9. Interventional Case Studies
Figure 10. Observational Case Studies
Figure 11. Expanded Access Case Studies
Figure 12. Clinical Trials Report Years Considered
Figure 13. Global Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Clinical Trials Market Share by Region: 2022 VS 2033
Figure 16. Global Clinical Trials Market Share by Players in 2022
Figure 17. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trials Revenue in 2022
Figure 19. North America Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Clinical Trials Market Share by Country (2018-2033)
Figure 21. United States Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Clinical Trials Market Share by Country (2018-2033)
Figure 25. Germany Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Clinical Trials Market Share by Region (2018-2033)
Figure 33. China Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Clinical Trials Market Share by Country (2018-2033)
Figure 41. Mexico Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Clinical Trials Market Share by Country (2018-2033)
Figure 45. Turkey Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Clinical Trials Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Quintiles IMS Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 48. Paraxel International Corporation Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 49. Charles River Laboratories Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 50. ICON plc Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 51. SGS SA Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 52. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 53. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 54. PRA Health Sciences Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 55. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 56. INC Research Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries